Abstract
BackgroundGenotyping drug resistance testing methods for HIV-1 are continually evolving, as exemplified by Next Generation Sequencing (NGS) technology, which is gradually replacing Sanger sequencing (SS) in clinical diagnostics. A comparison...
Paper version not known (Free)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have